多参数磁共振成像在前列腺穿刺活检前检测前列腺癌的诊断准确性
OBJECTIVES: To determine the extent to which clinically significant prostate cancer (csPCa) can be detected in a routine National Health Service setting in men with no previous biopsy, when multiparametric magnetic resonance imaging (mpMRI) is introduced into the diagnostic pathw…
要点
- mpMRI的PI-RADS评分越高,csPCa检出率越高。
- mpMRI诊断csPCa的敏感性82%、阴性预测值85%。
- 正常mpMRI不能排除csPCa,可用于医患共同决策。
核心结论
- 在常规临床环境中,未穿刺男性mpMRI的PI-RADS评分越高,csPCa检出率越高。
- 正常mpMRI不能排除csPCa,但可辅助决定是否进行穿刺及后续治疗。
研究设计与样本
- 以经会阴或经直肠超声引导穿刺活检为参考标准,csPCa定义为Gleason评分≥3+4。
主要发现
- 经会阴和经直肠超声引导穿刺的中位针数分别为10针和6针。
- csPCa总检出率为37%;PI-RADS 1和2中csPCa比例为15%,PI-RADS 5中为86%。
- mpMRI诊断csPCa的敏感性82%、阴性预测值85%、特异性59%、阳性预测值54%。
关键数值与推荐
- csPCa定义为Gleason评分≥3+4。
- mpMRI诊断csPCa的敏感性82%、阴性预测值85%、特异性59%、阳性预测值54%。
- PI-RADS 1和2中csPCa比例为15%,PI-RADS 5中为86%。
临床怎么用
- 在未穿刺男性中,可根据mpMRI的PI-RADS评分评估csPCa风险。
- mpMRI结果可用于医患共同决策是否进行穿刺活检。
- 正常mpMRI不能排除csPCa,需结合临床综合判断。
局限性
- 研究为回顾性设计。
- 未报告漏诊癌症的随访数据。
- mpMRI PI-RADS评分低的男性接受穿刺的可能性更低,这种选择偏倚可能高估csPCa检出率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the extent to which clinically significant prostate cancer (csPCa) can be detected in a routine National Health Service setting in men with no previous biopsy, when multiparametric magnetic resonance imaging (mpMRI) is introduced into the diagnostic pathway. PATIENTS AND METHODS: In all, 1 090 mpMRIs were performed between July 2013 and April 2016 in biopsy-naïve men with an abnormal prostate-specific antigen level and/or digital rectal examination. Data were collected from patient records at the Royal Devon and Exeter NHS Foundation Trust. mpMRI Prostate Imaging Reporting and Data System (PI-RADS) scores were compared to transperineal or transrectal ultrasonography (TRUS)-guided biopsy findings as the reference standard. csPCa was defined as Gleason score of ≥3+4. The diagnostic accuracy of mpMRI was also assessed. RESULTS: The mpMRI was interpretable in 1 023 men and 792 underwent biopsy, of which 106 were transperineal. The median number of cores taken in transperineal and TRUS-guided biopsy were 10 and 6, respectively. The detection rate of csPCa was 37%; csPCa rose from 15% of PI-RADS 1 and 2 to 86% of PI-RADS 5. The sensitivity, negative predictive value, specificity, and positive predictive value were 82%, 85%, 59% and 54%, respectively. The study is limited by its retrospective nature and lack of reporting of follow-up for 'missed cancers'. Men with low mpMRI PI-RADS were also less likely to undergo biopsy. Whilst this selection bias may overestimate the detection rate of csPCa, this reflects the shared decisions patients and clinicians make in day-to-day practice outside of research centres. CONCLUSION: In a routine clinical setting, the higher the mpMRI PI-RADS, the greater the detection rate of csPCa in biopsy-naïve men. A normal mpMRI does not exclude csPCa; however, mpMRI may have utility in informing shared-decision making on whether to proceed to biopsy and subsequent treatment.
引用
- Otti VC, Miller C, Powell RJ, et al. The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer. BJU Int. 2018. PMID: 29804315. doi:10.1111/bju.14420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。